Article Text

Download PDFPDF
Review
Inflammatory bowel disease in India: challenges and opportunities
  1. Alice Snell1,
  2. Jonathan Segal2,
  3. Jimmy Limdi3,4,
  4. Rupa Banerjee5
  1. 1Department of Gastroenterology, Northwick Park Hospital, London, UK
  2. 2Department of Gastroenterology, Saint Mary's Hospital Medical School, London, UK
  3. 3Department of Gastroenterology, Pennine Acute Hospitals NHS Trust, Manchester, UK
  4. 4Manchester Academic Health Science Centre, Manchester, UK
  5. 5Asian Institute of Gastroenterology, Hyderabad, Telangana, India
  1. Correspondence to Dr Alice Snell, Northwick Park Hospital, Harrow HA1 3UJ, UK; alice.snell{at}nhs.net

Abstract

Evidence is emerging that inflammatory bowel diseases (IBDs) are becoming increasingly prevalent in developing countries, altering the previously held view that these were diseases of the West. Within this is a substantial increase in the burden of this disease in India, a matter of great importance to the country itself as well as in furthering our understanding of the disease. There is comparatively less data on this, both from the epidemiological standpoint as well as on disease pathogenesis in this particular cohort and is very much a subject matter of evolving understanding and research. This article aims to look at the changing global distribution of the disease and its implications. The Indian disease phenotype, and the aetiology of disease development will also be addressed with particular focus on differing pathogenetic processes in the Indian subpopulation, with consideration of what clues may be offered by the increasing incidence of the disease in this developing nation. Available evidence will be evaluated with the objective of providing a comprehensive overview of the development of IBD in India.

  • inflammatory bowel disease
  • IBD
  • epidemiology
  • ulcerative colitis
  • Crohn's disease
View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors Conceptualisation was done by JS and RB. All authors contributed to the article content. Drafting was done by AS, with critical revision by JL, JS and RB. All authors approved the final manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.